Sarcomeric protein mutations in dilated cardiomyopathy

Heart Failure Reviews

Volumn 10, Issue 3, 2005, Pages 225-235

  Chang, Audrey N ^a   Potter, James D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac muscle; Dilated cardiomyopathy; Mutations; Sarcomeric proteins

Indexed keywords

ACTIN; AMINO ACID; BINDING PROTEIN; CONNECTIN; CYTOSKELETON PROTEIN; DESMIN; LIM PROTEIN; MUSCLE PROTEIN; MUTANT PROTEIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN BETA; SARCOMERIC PROTEIN; TELETHONIN CAP; TROPOMYOSIN; TROPONIN C; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG; VINCULIN;

CONGESTIVE CARDIOMYOPATHY; GENE MUTATION; HUMAN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SARCOLEMMA; SARCOMERE;

ACTINS; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CARRIER PROTEINS; CYTOSKELETON; MUSCLE PROTEINS; MUTATION; MYOCARDIUM; MYOSIN HEAVY CHAINS; NONMUSCLE MYOSIN TYPE IIB; PROTEIN KINASES; SARCOMERES; TROPOMYOSIN; TROPONIN;

EID: 30944435503     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10741-005-5252-6     Document Type: Review

References (68)

1. Richardson P, et al., Report of the 1995 world health organization/ international society and federation of cardiology task force on the definition and classification of cardiomyopathies. Circulation 1996;93(5):841-842.
2. Kamisago M, et al., Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000;343(23):1688-1696. 10.1056/ NEJM200012073432304
3. Mestroni L, et al., Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol 1999;34(1):181-190. 10.1016/S0735-1097(99)00172-2
4. Harada K, Potter JD. Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction. J Biol Chem 2004;279(15):14488-14495. 10.1074/jbc.M309355200
5. Knollmann BC, et al., Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy. J Biol Chem 2001;276(13):10039-10048. 10.1074/jbc.M006745200
6. Szczesna D, et al., Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy. J Biol Chem 2000;275(1):624-630. 10.1074/jbc.275.1.624
7. Venkatraman G, et al., Characterization of troponin T dilated cardiomyopathy mutations in the fetal troponin isoform. J Biol Chem, 2004.
8. Venkatraman G, et al., Different functional properties of troponin T mutants that cause dilated cardiomyopathy. J Biol Chem 2003;278(43):41670-41676. 10.1074/jbc.M302148200
9. Daehmlow S, et al., Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem Biophys Res Commun 2002;298(1):116-120. 10.1016/S0006-291X(02)02374-4
10. Nanni L, et al., Hypertrophic cardiomyopathy: Two homozygous cases with "typical" hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathy. Biochem Biophys Res Commun 2003;309(2):391-398. 10.1016/j.bbrc.2003.08.014
11. Villard E, et al., Mutation screening in dilated cardiomyopathy: Prominent role of the beta myosin heavy chain gene. Eur Heart J 2005;26(8):794-803. 10.1093/eurheartj/ehi193
12. Karkkainen S, et al., Two novel mutations in the beta-myosin heavy chain gene associated with dilated cardiomyopathy. Eur J Heart Fail 2004;6(7):861-868. 1:CAS:528:DC%2BD2cXhtVWjtrnN
13. Hartzell HC, Sale WS. Structure of C protein purified from cardiac mus cle. J Cell Biol 1985;100(1):208-215. 10.1083/jcb.100.1.208
14. Swan RC, Fischman DA. Electron microscopy of C-protein molecules from chicken skeletal muscle. J Muscle Res Cell Motil 1986;7(2):160-166. 10.1007/BF01753417
15. Gautel M, et al., Phosphorylation switches specific for the cardiac isoform of myosin binding protein-C: A modulator of cardiac contraction? Embo J 1995;14(9):1952-1960. 1:CAS:528:DyaK2MXlvVCqsr8%3D
16. Weisberg A, Winegrad S. Alteration of myosin cross bridges by phosphorylation of myosin-binding protein C in cardiac muscle. Proc Natl Acad Sci USA, 1996. 93(17):8999-9003
17. Harris SP, et al., Hypertrophic cardiomyopathy in cardiac myosin binding protein-C knockout mice. Circ Res 2002;90(5):594-601. 10.1161/ 01.RES.0000012222.70819.64
18. Konno T, et al., A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients. J Am Coll Cardiol 2003;41(5):781-786. 10.1016/S0735-1097(02)02957-1
19. Shimizu M, et al., Gene mutations in adult Japanese patients with dilated cardiomyopathy. Circ J 2005;69(2):150-153. 10.1253/circj.69.150
20. Rayment I, et al., Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. Proc Natl Acad Sci USA, 1995;92(9):3864-3868. 1:CAS:528:DyaK2MXlsVSksr4%3D
21. Olson TM, et al., Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998;280(5364):750-752. 10.1126/ science.280.5364.750
22. Geeves MA, Holmes KC. Structural mechanism of muscle contraction. Annu Rev Biochem, 1999;68:687-728.
23. Olson TM, et al., Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy. J Mol Cell Cardiol, 2001;33(4):723-732. 10.1006/jmcc.2000.1339
24. Regitz-Zagrosek V, et al., Novel mutation in the alpha-tropomyosin gene and transition from hypertrophic to hypocontractile dilated cardiomyopathy. Circulation 2000;102(17):E112-E116. 1:STN:280:DC%2BD3crgt1eltg%3D%3D
25. Golitsina N, et al., Effects of two familial hypertrophic cardiomyopathy- causing mutations on alpha-tropomyosin structure and function. Biochemistry 1997;36(15):4637-4642. 10.1021/bi962970y
26. Golitsina N, et al., Effects of two familial hypertrophic cardiomyopathy- causing mutations on alpha-tropomyosin structure and function. Biochemistry 1999;38(12):3850.
27. Prabhakar R, et al., A familial hypertrophic cardiomyopathy alpha-tropomyosin mutation causes severe cardiac hypertrophy and death in mice. J Mol Cell Cardiol 2001;33(10):1815-1828. 10.1006/jmcc.2001.1445
28. Bing W, et al., Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha -tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. J Mol Cell Cardiol 2000;32(8):1489-1498. 10.1006/ jmcc.2000.1182
29. Wernicke D, et al., alpha-Tropomyosin mutations Asp(175)Asn and Glu(180)Gly affect cardiac function in transgenic rats in different ways. Am J Physiol Regul Integr Comp Physiol 2004;287(3):R685-R695. 1:CAS:528:DC%2BD2cXnvVaqur8%3D
30. Gomes AV, Potter JD. Molecular and cellular aspects of troponin cardiomyopathies. Ann N Y Acad Sci 2004;1015:214-224. 10.1196/ annals.1302.018
31. Potter JD, Sheng Z, Pan B, Zhao J. A direct regulatory role for troponin T and a dual role for troponin C in the Ca2+ regulation of muscle contraction. The Journal of Biological Chemistry 1995;270(6):2557-2562. 1:CAS:528:DyaK2MXjs1Kmt74%3D
32. Zhang R, et al., Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res, 1995;76(6):1028-1035. 1:CAS:528:DyaK2MXlvVShtrY%3D
33. Zhang R, Zhao J, Potter JD. Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca2+ affinity of cardiac troponin C. J Biol Chem 1995;270(51):30773-30780. 10.1074/ jbc.270.51.30787
34. Noland TA, Jr., et al., Cardiac troponin I mutants. Phosphorylation by protein kinases C and A and regulation of Ca(2+)-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem 1995;270(43):25445-25454.
35. Noland TA, Jr, et al., Differential regulation of cardiac actomyosin S-1 MgATPase by protein kinase C isozyme-specific phosphorylation of specific sites in cardiac troponin I and its phosphorylation site mutants. Biochemistry 1996;35(47):14923-14931. 10.1021/bi9616357
36. Noland TA, Jr, Raynor RL, Kuo JF. Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites. J Biol Chem 1989;264(34):20778-20785. 1:CAS:528:DyaK3cXjtlWr
37. Bowling N, et al., Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation 1999;99(3):384-391. 1:STN:280:DyaK1M7hsleiuw%3D%3D
38. Sumandea MP, et al., Molecular and integrated biology of thin filament protein phosphorylation in heart muscle. Ann N Y Acad Sci 2004;1015:39-52. 10.1196/annals.1302.004
39. Noguchi T, et al., Thin-filament-based modulation of contractile performance in human heart failure. Circulation 2004;110(8):982-987. 10.1161/01.CIR.0000139334.43109.F9
40. Gomes AV, Harada K, Potter JD. A mutation in the N-terminus of Troponin I that is associated with hypertrophic cardiomyopathy affects the Ca2+ sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin. Journal of Molecular and Cellular Cardiology, 2005, in press.
41. Bodor GS, et al., Troponin I phosphorylation in the normal and failing adult human heart. Circulation, 1997;96(5):1495-1500. 1:CAS:528:DyaK2sXmtFeis7k%3D
42. Wattanapermpool J, Guo X, Solaro RJ. The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated. J Mol Cell Cardiol 1995;27(7):1383-1391. 10.1006/ jmcc.1995.0131
43. Fujino N, et al., Cardiac troponin T Arg92Trp mutation and progression from hypertrophic to dilated cardiomyopathy. Clin Cardiol 2001;24(5):397-402. 1:STN:280:DC%2BD3M3ltVChtQ%3D%3D
44. Fujino N, et al., A novel mutation Lys273Glu in the cardiac troponin T gene shows high degree of penetrance and transition from hypertrophic to dilated cardiomyopathy. Am J Cardiol 2002;89(1):29-33. 10.1016/ S0002-9149(01)02158-0
45. Mogensen J, et al., Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004;44(10):2033-2040. 10.1016/j.jacc.2004.08.027
46. Li D, et al., Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation 2001;104(18):2188-2193. 1:CAS:528:DC%2BD3MXptVCru7w%3D
47. Stefanelli CB, et al., Novel troponin T mutation in familial dilated cardiomyopathy with gender-dependant severity. Mol Genet Metab 2004;83(1/ 2):188-196. 1:CAS:528:DC%2BD2cXotF2nt74%3D
48. Morimoto S, Lu QW, Harada K, Takahashi-Yanaga F, Minakami R, Ohta M, Sasaguri T, Ohtsuki I. Ca2+-desensitizing effect of a deletion mutation deltaK210 in cardiac troponin T that causes familial dilated cardiomyopathy. PNAS 2002;99(2):913-918. 10.1073/pnas.022628899
49. Murphy RT, et al., Novel mutation in cardiac troponin I in recessive idiopath ic dilated cardiomyopathy. Lancet 2004;363(9406):371-372. 10.1016/S0140-6736(04)15468-8
50. Gregorio CC, et al., The NH2 terminus of titin spans the Z -disc: Its interaction with a novel 19-kD ligand (T -cap) is required for sarcomeric integrity. J Cell Biol 1998;143(4):1013-1027. 10.1083/ jcb.143.4.1013
51. Sorimachi H, et al., Tissue-specific expression and alpha-actinin binding properties of the Z -disc titin: Implications for the nature of vertebrate Z -discs. J Mol Biol 1997;270(5):688-695. 10.1006/ jmbi.1997.1145
52. Makarenko I, et al., Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res 2004;95(7):708-716. 10.1161/01.RES.0000143901.37063.2f
53. Zou P, et al., Solution scattering suggests cross-linking function of telethon in in the complex with titin. J Biol Chem 2003;278(4):2636-2644. 10.1074/jbc.M210217200
54. Itoh-Satoh M, et al., Titin mutations as the molecular basis for dilated cardiomyopathy. Biochem Biophys Res Commun 2002;291(2):385-393. 10.1006/ bbrc.2002.6448
55. Granzier H, Labeit S. Cardiac titin: An adjustable multi-functional spring. J Physiol 2002;541(Pt 2):335-342. 1:CAS:528:DC%2BD38XlsVWjtLw%3D
56. Arber S, et al., MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 1997;88(3):393-403. 10.1016/S0092-8674(00)81878-4
57. Knoll R, et al., The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 2002;111(7):943-955. 10.1016/S0092-8674(02)01226-6
58. Mohapatra B, et al., Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab 2003;80(1/2):207-215. 1:CAS:528:DC%2BD3sXotVChtrY%3D
59. Hayashi T, et al., Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Cardiol, 2004;44(11):2192-2201. 10.1016/j.jacc.2004.08.058
60. Frey N, Richardson JA, Olson EN. Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl Acad Sci USA, 2000;97(26):14632-14637. 1:CAS:528:DC%2BD3MXitVGiuw%3D%3D
61. Milner DJ, et al., Disruption of muscle architecture and myocardial degenerat ion in mice lacking desmin. J Cell Biol 1996;134(5):1255-1270. 10.1083/jcb.134.5.1255
62. Olson TM, et al., Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 2002;105(4):431-437. 10.1161/ hc0402.102930
63. Epstein ND, Davis JS. Sensing stretch is fundamental. Cell 2003;112(2):147-150. 10.1016/S0092-8674(03)00037-0
64. Wang W, et al., Intracellular action of matrix metall- oproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 2002;106(12):1543-1549. 1:CAS:528:DC%2BD38XntVKktr8%3D
65. Sariahmetogly M, Skrzypiec M, Leon H, Sawicka J, Holmes C, Berthiamume GS, Sawicki G, Schulz R. Phosphorylation status of matrix metalloproteinase-2 and potential role in myocardial ischemia-reperfusion injury. Circulation 2004;110(17):III-267.
66. Li YY, et al., Downregulation of matrix metalloproteinases and reduction in collagen damage in the failing human heart after support with left ventricular assist devices. Circulation 2001;104(10):1147-1152. 1:CAS:528:DC%2BD3MXotlWnsbs%3D
67. Spinale FG, et al., A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 2000;102(16):1944-1949. 1:CAS:528:DC%2BD3cXnvV2qtb4%3D
68. Gerull B, et al., Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002;30(2):201-204. 10.1038/ng815